Hydroxychloroquine lung pharmacokinetics in critically ill patients with COVID-19

Different dosage regimens of hydroxychloroquine (HCQ) have been used to manage COVID-19 (coronavirus disease 2019) patients, with no information on lung exposure in this population. The aim of our study was to evaluate HCQ concentrations in the lung epithelial lining fluid (ELF) in patients infected...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz, S., Concordet, D., Lanot, T., Georges, B., Goudy, P., Baklouti, S., Mané, C., Losha, E., Vinour, H., Rousset, D., Lavit, M., Minville, V., Conil, J-M, Gandia, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698654/
https://www.ncbi.nlm.nih.gov/pubmed/33259916
http://dx.doi.org/10.1016/j.ijantimicag.2020.106247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698654/
https://www.ncbi.nlm.nih.gov/pubmed/33259916
http://dx.doi.org/10.1016/j.ijantimicag.2020.106247

Ejemplares similares